Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Australia
    • Dairy
    • 1 - 100 Employee
    • Owner
      • Jul 2018 - Present

      HISTORY The word Kefir is derived from the Turkish word “Keif” describing a state of feeling good and it’s as true now as it was then. Kefir originated in the Caucasus Mountains more than 2000 years ago and is the oldest known fermented milk drink. The secret of the Kefir grains, passed down from generation to generation, was considered a source of family and tribal wealth. Traditionally, Kefir was made by mixing Kefir grains with fresh, raw, cow or goat milk which was then left in goatskin leather bags to ferment. It was customary to leave the bag outside the door and let anyone entering, kick or shake the bag. This assisted the culture process INNOVATION. LEARNING FROM THE PAST The average modern diet is full of processed foods and an increased occurrence of digestive and gut issues. Seeing these issues on the rise, Babushka set out to look for traditional preparations that could help. We found kefir, a cultured fermented milk drink that has a much stronger probiotic profile than yoghurt. Probiotics, or “good bacteria,” are living organisms that can help maintain regular bowel movements, treat certain digestive conditions, and support the immune system. Traditionally, kefir has a reputation for promoting longevity and as an immune booster. We have enriched our kefir with ABC probiotics (Acidophilus, bifido and casei) and prebiotic inulin fibre, developing a product that offers health benefits beyond its basic nutritional value.

    • Australia
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Pharmacy Services Director
      • Feb 2019 - Present
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Head of Retail ANZ
      • Apr 2010 - Aug 2018

      Sun Pharma's global acquisition of Ranbaxy was finalised at the end of March 2015. The combined company is now the 5th largest speciality generics company globally. This good news comes on the tail of a bumper growth year for our local organisation and reinforces our position as a major generics supplier in Australia. While Ranbaxy Australia will now become a Sun Pharma company, this will not change our strategic focus of delivering a sustainable supply of low cost quality generics with no compromise on service.

    • United States
    • Medical Practices
    • 1 - 100 Employee
    • Co-founder & Owner
      • Jul 2008 - Jun 2013

      Established a complementary medicines company. Our products are researched, developed and manufactured in Australia using natural and organic ingredients. We have established business partnerships with both independent pharmacies and pharmacy chains throughout Australia. We are supported nationally by our own field sales force and daily distribution is through all major national wholesalers. Established a complementary medicines company. Our products are researched, developed and manufactured in Australia using natural and organic ingredients. We have established business partnerships with both independent pharmacies and pharmacy chains throughout Australia. We are supported nationally by our own field sales force and daily distribution is through all major national wholesalers.

    • France
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Director Pharmacy Business
      • Jun 2006 - Jul 2008

      Responsible for all pharmacy channel business in Australia, including patent protected products, patent expired products, over-the-counter medications and generic medicines. Responsible for all pharmacy channel business in Australia, including patent protected products, patent expired products, over-the-counter medications and generic medicines.

    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • General Manager Sales & Operations
      • Apr 2004 - Jun 2006

      Joined Hexal, global generic medicines manufacturer, as GM Sales & Operations for Australia & NZ. Hexal was acquired by Novartis and merged with Sandoz, its generics division. Became GM for merged organisation responsible for hospital and pharmacy business. Was head-hunted by sanofi-aventis to head its pharmacy division. Joined Hexal, global generic medicines manufacturer, as GM Sales & Operations for Australia & NZ. Hexal was acquired by Novartis and merged with Sandoz, its generics division. Became GM for merged organisation responsible for hospital and pharmacy business. Was head-hunted by sanofi-aventis to head its pharmacy division.

    • Machinery Manufacturing
    • 700 & Above Employee
    • General Manager Corporate; Regional Manager; National Technical Services Manager; IS Manager
      • Apr 1988 - Apr 2004

      Initially joined Lansing Bagnell, a global electric industrial truck manufacturer headquartered in the UK. I joined as their Australia & NZ Information Systems Manager. Lansing was acquired by Linde Hydraulics. I worked through various management positions with extensive training from factories in the UK, Germany and France over 12 years. I helped set up technical and sales operations for Linde industrial trucks in Australia, NZ and Asia. I left Linde in 2004 as a General Manager, to join the Pharamceutical Industry.

Education

  • Australian Graduate School of Management
    executiveMBA, strategic business management
    2000 - 2003
  • UNSW
    BEng, Electrical Engineering
    1979 - 1982

Community

You need to have a working account to view this content. Click here to join now